Home Duke University Press
QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Neuro Oncol 1999 1(2):139-151; DOI:10.1215/15228517-1-2-139
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biegel, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Duke University Press

Symposium Childhood Brian Tumors

Cytogenetics and molecular genetics of childhood brain tumors

Jaclyn A. Biegel2

Division of Human Genetics and Molecular Biology, The Children's Hospital of Philadelphia and the Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

2 Address correspondence and reprint requests to Jaclyn Biegel, Ph.D., Room 1002 Abramson Research Center, The Children's Hospital of Philadelphia, 3516 Civic Center Boulevard, Philadelphia, PA 19104.

Abstract

Considerable progress has been made toward improving survival for children with brain tumors, and yet there is still relatively little known regarding the molecular genetic events that contribute to tumor initiation or progression. Nonrandom patterns of chromosomal deletions in several types of childhood brain tumors suggest that the loss or inactivation of tumor suppressor genes are critical events in tumorigenesis. Deletions of chromosomal regions 10q, 11 and 17p, for example, are frequent events in medulloblastoma, whereas loss of a region within 22q11.2, which contains the INI1 gene, is involved in the development of atypical teratoid and rhabdoid tumors. A review of the cytogenetic and molecular genetic changes identi-fied to date in childhood brain tumors will be presented.




This article has been cited by other articles:


Home page
 Am. J. Neuroradiol.Home page
S.P. Meyers, Z.P. Khademian, J.A. Biegel, S.H. Chuang, D.N. Korones, and R.A. Zimmerman
Primary intracranial atypical teratoid/rhabdoid tumors of infancy and childhood: MRI features and patient outcomes.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 962 - 971.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. M. Hilden, S. Meerbaum, P. Burger, J. Finlay, A. Janss, B. W. Scheithauer, A. W. Walter, L. B. Rorke, and J. A. Biegel
Central Nervous System Atypical Teratoid/Rhabdoid Tumor: Results of Therapy in Children Enrolled in a Registry
J. Clin. Oncol., July 15, 2004; 22(14): 2877 - 2884.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
T. J. MacDonald, B. R. Rood, M. R. Santi, G. Vezina, K. Bingaman, P. H. Cogen, and R. J. Packer
Advances in the Diagnosis, Molecular Genetics, and Treatment of Pediatric Embryonal CNS Tumors
Oncologist, April 1, 2003; 8(2): 174 - 186.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. A. Biegel, B. Fogelgren, J.-Y. Zhou, C. D. James, A. J. Janss, J. C. Allen, D. Zagzag, C. Raffel, and L. B. Rorke
Mutations of the INI1 Rhabdoid Tumor Suppressor Gene in Medulloblastomas and Primitive Neuroectodermal Tumors of the Central Nervous System
Clin. Cancer Res., July 1, 2000; 6(7): 2759 - 2763.
[Abstract] [Full Text]


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 1999 by Society for Neuro-Oncology